MYDGF and metabolic dysfunction-associated steatotic liver disease: Bone marrow transplantation or myeloid-specific overexpression of MYDGF can ameliorate NAFLD through the PKC/IKKβ/NF-κB signaling pathway (Ding et al. 2023).